| Company Name: |
Nextpeptide Inc |
| Tel: |
+86-0571-81612335 +8613336028439 |
| Email: |
sales@nextpeptide.com |
|
| | m-PEG5-phosphonic acid ethyl ester Basic information |
| Product Name: | m-PEG5-phosphonic acid ethyl ester | | Synonyms: | m-PEG5-phosphonic acid ethyl ester;1-[2-[2-[2-(2-diethoxyphosphorylethoxy)ethoxy]ethoxy]ethoxy]-2-methoxyethane;Phosphonic acid, P-3,6,9,12,15-pentaoxahexadec-1-yl-, diethyl ester | | CAS: | 1807512-42-0 | | MF: | C15H33O8P | | MW: | 372.39 | | EINECS: | | | Product Categories: | | | Mol File: | 1807512-42-0.mol |  |
| | m-PEG5-phosphonic acid ethyl ester Chemical Properties |
| Boiling point | 437.8±40.0 °C(Predicted) | | density | 1.079±0.06 g/cm3(Predicted) |
| | m-PEG5-phosphonic acid ethyl ester Usage And Synthesis |
| Description | m-PEG9-phosphonic acid ethyl ester is a PEG chain linker. The hydrophilic PEG linkers increase the water solubility of compound in aqueous media. Longer PEG chains have better water solubility properties relative to shorter PEG chains. | | Uses | m-PEG5-phosphonic acid ethyl ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | m-PEG5-phosphonic acid ethyl ester Preparation Products And Raw materials |
|